BioLife Solutions, Inc. (BLFS) Quick Ratio
- Quick ratio · latest quarter: Value 6.67×; Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | 6.67× | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. $93.07M ÷ $13.95M ≈ 6.67× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | 93.07M USD | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 13.95M USD | Liabilities, Current |
| Cash and equivalents | 24.00M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 58.42M USD | Debt Securities, Available-for-sale, Current |
| Customer receivables | 10.65M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 35.59M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $93.07M | $13.95M | $24.00M | $58.42M | $10.65M | $35.59M | 6.67× |
| 2026-03-31 | $94.05M | $18.25M | $22.82M | $58.17M | $13.06M | $32.83M | 5.15× |
| 2025-12-31 | $96.88M | $22.98M | $33.04M | $55.89M | $7.95M | $30.16M | 4.22× |
| 2025-09-30 | $89.80M | $27.15M | $29.48M | $49.47M | $10.84M | $27.82M | 3.31× |
| 2025-06-30 | $91.83M | $28.31M | $31.90M | $49.86M | $10.06M | $27.69M | 3.24× |
| 2025-03-31 | $97.75M | $27.72M | $66.94M | $21.64M | $9.17M | $27.57M | 3.53× |
| 2024-12-31 | $113.75M | $32.73M | $95.39M | $9.20M | $9.17M | $29.01M | 3.48× |
| 2024-09-30 | $52.11M | $32.17M | $23.98M | $10.21M | $17.92M | $32.18M | 1.62× |
| 2024-06-30 | $52.20M | $30.82M | $22.01M | $12.12M | $18.06M | $32.50M | 1.69× |
| 2024-03-31 | $63.85M | $38.66M | $29.69M | $15.58M | $18.57M | $43.41M | 1.65× |
| 2023-12-31 | $70.35M | $42.18M | $35.41M | $16.29M | $18.66M | $43.46M | 1.67× |
| 2023-09-30 | $65.58M | $42.62M | $19.23M | $21.79M | $24.56M | $43.35M | 1.54× |
| 2023-06-30 | $73.12M | $39.59M | $21.40M | $24.86M | $26.86M | $39.18M | 1.85× |
| 2023-03-31 | $85.23M | $47.32M | $19.11M | $35.78M | $30.34M | $41.33M | 1.80× |
| 2022-12-31 | $96.64M | $44.58M | $19.44M | $43.26M | $33.94M | $34.90M | 2.17× |
| 2022-09-30 | $94.06M | $36.95M | $27.04M | $34.58M | $32.44M | $33.75M | 2.55× |
| 2022-06-30 | $77.80M | $33.30M | $24.00M | $22.55M | $31.26M | $33.34M | 2.34× |
| 2022-03-31 | (m) | $35.04M | $59.46M | (m) | $24.27M | $30.20M | (m) |
| 2021-12-31 | (m) | $40.38M | $69.86M | (m) | $23.22M | $28.34M | (m) |
| 2021-09-30 | (m) | $35.79M | $75.10M | (m) | $20.23M | $29.70M | (m) |
| 2021-06-30 | (m) | $31.27M | $76.25M | (m) | $21.09M | $25.87M | (m) |
| 2021-03-31 | (m) | $16.38M | $89.01M | (m) | $10.67M | $11.67M | (m) |
| 2020-12-31 | (m) | $15.57M | $90.40M | (m) | $8.01M | $11.60M | (m) |
| 2020-09-30 | (m) | $8.36M | $93.98M | (m) | $6.09M | $11.04M | (m) |
| 2020-06-30 | (m) | $7.49M | $29.88M | (m) | $4.35M | $10.89M | (m) |
| 2020-03-31 | (m) | $25.46M | $6.40M | (m) | $8.21M | $10.83M | (m) |
| 2019-12-31 | (m) | $7.67M | $6.45M | (m) | $5.34M | $10.97M | (m) |
| 2019-09-30 | (m) | $4.94M | $21.20M | (m) | $4.31M | $5.69M | (m) |
| 2019-06-30 | (m) | $3.09M | $19.62M | (m) | $3.83M | $5.31M | (m) |
| 2019-03-31 | (m) | $2.70M | $31.82M | (m) | $2.93M | $4.06M | (m) |
| 2019-03-30 | (m) | (m) | $31.82M | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $1.94M | $30.66M | (m) | $3.04M | $3.51M | (m) |
| 2018-09-30 | (m) | $2.10M | $32.38M | (m) | $2.70M | $2.91M | (m) |
| 2018-06-30 | (m) | $1.66M | $14.17M | (m) | $2.17M | $2.12M | (m) |
| 2018-03-31 | (m) | $1.31M | $7.03M | (m) | $1.04M | $1.84M | (m) |
| 2018-03-30 | (m) | (m) | $7.03M | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $1.51M | $6.66M | (m) | $1.02M | $1.85M | (m) |
| 2017-09-30 | (m) | $1.09M | $2.83M | (m) | $1.36M | $1.86M | (m) |
| 2017-06-30 | (m) | $1.05M | $2.31M | (m) | $1.17M | $1.77M | (m) |
| 2017-03-31 | (m) | $1.09M | $2.29M | (m) | $1.06M | $1.81M | (m) |
| 2016-12-31 | (m) | $1.13M | $1.41M | (m) | $1.19M | $1.76M | (m) |
| 2016-09-30 | (m) | $3.46M | $1.37M | (m) | $1.31M | $1.90M | (m) |
| 2016-06-30 | (m) | $2.26M | $1.32M | (m) | $1.28M | $1.91M | (m) |
| 2016-03-31 | (m) | $1.48M | $1.66M | (m) | $1.19M | $2.02M | (m) |
| 2015-12-31 | (m) | $1.73M | $2.17M | (m) | $929.29K | $1.83M | (m) |
| 2015-09-30 | (m) | $1.63M | $2.35M | (m) | $792.27K | $1.78M | (m) |
| 2015-06-30 | (m) | $1.16M | $3.90M | (m) | $809.39K | $1.32M | (m) |
| 2015-03-31 | (m) | $1.46M | $2.97M | (m) | $851.04K | $1.24M | (m) |
| 2014-12-31 | (m) | $1.26M | $2.54M | (m) | $901.62K | $965.22K | (m) |
| 2014-09-30 | (m) | $833.01K | $3.28M | (m) | $775.08K | $717.62K | (m) |
| 2014-06-30 | (m) | $613.00K | $5.90M | (m) | $566.54K | $678.16K | (m) |
| 2014-03-31 | (m) | $1.06M | $12.84M | (m) | $1.33M | $297.11K | (m) |
| 2013-12-31 | (m) | $1.63M | $156.27K | (m) | $1.01M | $420.92K | (m) |
| 2013-09-30 | (m) | $1.23M | $79.29K | (m) | $1.03M | $409.19K | (m) |
| 2013-06-30 | (m) | $1.42M | $76.20K | (m) | $980.97K | $593.14K | (m) |
| 2013-03-31 | (m) | $1.47M | $61.52K | (m) | $976.16K | $676.44K | (m) |
| 2012-12-31 | (m) | $1.37M | $196.48K | (m) | $600.15K | $656.40K | (m) |
| 2012-09-30 | (m) | $1.47M | $7.53K | (m) | $797.94K | $849.21K | (m) |
| 2012-06-30 | (m) | $1.02M | $155.35K | (m) | $359.19K | $916.81K | (m) |
| 2012-03-31 | (m) | $687.81K | $70.52K | (m) | $471.82K | $763.97K | (m) |
| 2011-12-31 | (m) | $579.25K | $16.86K | (m) | $547.14K | $505.96K | (m) |
| 2011-09-30 | (m) | $516.15K | $20.12K | (m) | $458.68K | $475.13K | (m) |
| 2011-06-30 | (m) | $502.77K | $36.15K | (m) | $395.32K | $509.57K | (m) |
| 2011-03-31 | (m) | (m) | $35.10K | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $340.70K | $3.21K | (m) | $338.90K | $410.49K | (m) |
| 2010-09-30 | (m) | (m) | $298.00 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $67.88K | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $139.15K | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |